Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Antimicrobial Agents and Chemotherapy|November 29, 2017
Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in JapanPreethi Krishnan, Gretja Schnell, Rakesh Tripathi, et al.Journal of Medical Virology|August 27, 2017
Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavirGretja Schnell, Rakesh Tripathi, Preethi Krishnan, et al.Antimicrobial Agents and Chemotherapy|February 15, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor PibrentasvirTeresa I Ng, Preethi Krishnan, Tami Pilot-Matias, et al.The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.Antimicrobial Agents and Chemotherapy|December 3, 2014
In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450Tami Pilot-Matias, Rakesh Tripathi, Daniel Cohen, et al.Viruses|August 30, 2018
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 InfectionTeresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, et al.Antimicrobial Agents and Chemotherapy|November 1, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor GlecaprevirTeresa I Ng, Rakesh Tripathi, Thomas Reisch, et al.Journal of Medicinal Chemistry|April 15, 2018
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)Rolf Wagner, John T Randolph, Sachin V Patel, et al.Journal of Medicinal Chemistry|January 10, 2014
Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5ADavid A DeGoey, John T Randolph, Dachun Liu, et al.Pageof 4